Investors originally expected the Food and Drug Administration to approve Galvus by Nov. 30 of last year, but the FDA delayed its decision by three months in order to further scrutinize a series of skin reactions seen in primates who had received the drug.
Specifically, the tablet was spotted in the floorspace occupied by LG's new series of WiFi-connected Thinq appliances sporting an LG home automation skin or app.